More than 30 companies to produce generic version of Pfizer's COVID pill
ABC News
The U.N.-backed Medicines Patent Pool announced Thursday it has signed an agreement with 35 companies to produce generic versions of Pfizer’s COVID-19 antiviral pill.
The United Nations-backed Medicines Patent Pool announced Thursday it has signed an agreement with 35 companies around the globe to produce generic versions of Pfizer's COVID-19 antiviral pill.
The agreement will allow the treatment to be supplied to 95 low- and middle-income countries, home to more than half of the world's population, according to the MPP.
Clinical trial data has shown the pill, sold under the brand name Paxlovid, reduces the risk of hospitalization and death from COVID by 89% if taken within three days of the onset of symptoms.
Paxlovid is currently given as three pills twice daily over the course of five days.
